LYZZ Capital
Overview
LYZZ Capital is a venture capital firm specialized in seed, early, and expansion stage venture investments.
Investment Focus
- Focus on unmet medical needs
- Large market potential in China
- Innovative healthcare technologies
Portfolio Companies
Reach LYZZ Capital directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about LYZZ Capital
What sectors does LYZZ Capital invest in?
LYZZ Capital invests in Healthcare, Medical Devices, Medical Services and Medical Digitalization, and is based in China. LYZZ Capital is listed as a vc in the ConnectSafely investor database.
What stage does LYZZ Capital invest at?
LYZZ Capital backs companies at Seed and Early Stage.
Which regions does LYZZ Capital invest in?
LYZZ Capital invests across United States and China.
Who are the partners at LYZZ Capital?
Team members listed for LYZZ Capital include Kevin Li (Co-Founder and Managing Partner) and Xiakai Cheng (Principal).
What companies has LYZZ Capital invested in?
LYZZ Capital's portfolio includes Onchilles Pharma, Neurelis, Mojia Biotech, OncoMyx Therapeutics, JumpCode Genomics and Qpex Biopharma.
How do I contact LYZZ Capital?
LYZZ Capital's contact details — including LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of its partners.
Last updated · Source: ConnectSafely investor database
